New Jersey A 960: Requires bio-analytical or clinical laboratory conducting hepatitis C screening test to draw and store blood for confirmation test.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-01-14)

State: New Jersey · Session: 219 · Bill: A 960

Subjects: DISEASE, HEALTH FAC

Sponsors: Conaway, Herb, Holley, Jamel C.

View New Jersey A 960 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.